The University of California, Davis and InVixa Inc., a biopharmaceutical startup, have executed a licensing agreement for a novel method using inhaled statins to treat the severe respiratory disease known as COVID-19. The license, negotiated by the InnovationAccess team within the UC Davis Office of Research, provides exclusive access for InVixa to commercialize the technology […]
Campus leadership recently announced plans for a return to primarily in-person instruction starting fall 2021 while remaining vigilant in all critical prevention efforts and continuing to prioritize the health and well-being of the university community. We are expecting that all on-campus research activities, core facilities and research laboratories will return to full occupancy by the fall […]
(SACRAMENTO) — A research team led by UC Davis scientists used machine learning to engineer iSeroSnFR, a highly sensitive and selective sensor for serotonin, a neuromodulator that regulates mood and feelings of well-being and happiness. In a study, published Dec. 23 in Cell, the researchers developed and used the innovative sensor to track serotonin in […]
By Lisa Howard While the SARS-CoV-2 virus has dominated the news this past year, researchers continue to study the health effects of the Zika virus, which has been reported in 86 countries globally. The Zika virus is primarily transmitted by the bite of an infected mosquito from the Aedes genus. However, it can also be passed through […]
By Lisa Howard Over the past 10 months, K-12 school districts in California have faced unprecedented challenges due to the COVID-19 pandemic. To help reduce the spread of the virus in spring 2020, districts largely transitioned to distance-learning, with some or all of the instruction happening online. To understand the potential impact of these instructional […]
By Lisa Howard Shasqi, a startup enabled with technology developed at the University of California, Davis, and the State University of New York at Albany, has launched a Phase 1 human clinical trial of its precision activated oncology therapeutic. Shasqi is a privately held, clinical-stage biotechnology company with a mission of developing precision activated oncology […]
Updated December 7, 2020 UC Davis has announced a Davis campus curtailment program for six workdays between December 21, 2020, and January 4, 2021. Although the campus has modified the curtailment from a hard closure to a soft closure, the Office of Research will continue with its original plan. Please submit all routine or known […]
